Oak Hospital opens in May
HUS Oak Hospital focusing on the treatment of eye diseases opens in Meilahti, Helsinki on May 12, 2025. Oak Hospital will improve the capacity to respond to the increasing need for ophthalmological treatment.

Oak Hospital is responsible for public specialized healthcare in ophthalmology in the Helsinki Metropolitan Area. The treatment of serious and rare eye diseases in Finland has also been centralized to the hospital.
Oak Hospital will serve approximately 1,000 patients every day. The hospital's new, adaptable facilities provide better conditions for effective treatment of eye diseases and the capability to respond to the increasing need for treatment.
“The larger facilities enable us to shorten the waiting lists for surgery and treatment. The appointment facilities have been designed to enable us to utilise the model of joint appointments with a doctor, nurse and optician. This model has been developed by us, and it has enabled our physicians to see 50–100% more patients per day,” says Chief Physician Jukka Moilanen, Head of HUS Eye Diseases.
Oak Hospital has more than 200 appointment rooms, 15 operating rooms, 19 procedure and injection rooms, an inpatient ward with 12 beds and a medical equipment maintenance unit of its own. The hospital has training facilities and an operating room for teaching purposes.
Special needs of patients with a poor vision have been taken into account in Oak Hospital
Observations of what an accessible hospital is like were received from experts by experience with limited vision and from a client panel and used in the planning of Oak Hospital. Everyone using the hospital will benefit from the clear and accessible routes, color contrasts, lighting and anti-glare features.
“The starting point in the planning has been to create an environment that serves the patient’s needs and supports the work carried out by the staff. This creates the preconditions for a smooth hospital visit and a good patient experience,” explains Jari Pekola, an expert by experience at the Head and Neck Center.
In Oak Hospital, features helping patients with poor vision include a tactile map, signposts written in Braille in the elevator lobbies, as well as tactile pavement in the outdoor area and raised markings on the floor for users of a white cane. The smart sound beacons by the hospital entrances, in the elevator lobby of the underground car park and near the elevators help to navigate the hospital.
The number of ophthalmological patients has doubled
Age-related macular degeneration, glaucoma, diabetic retinopathy and cataract, which are the most common eye diseases among people aged over 65, account for almost two thirds of all specialised healthcare provided in ophthalmology.
“With the ageing of the population, the number of patients with eye diseases has doubled in the past ten years. Twenty per cent of all surgeries at HUS are eye surgeries. When people live longer, more and more of them will be patients at Eye Diseases,” Moilanen says.
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m., Fri and eves of public holidays 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
Keywords
Contacts
Jukka Moilanen
Head of Eye Diseases, Chief Physician
HUS, Head and Neck Center
tel. +358 50 448 1284
jukka.moilanen@hus.fi
Images





About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Behandlingsresultaten för hjärnaneurysm vid HUS i världsklass19.12.2025 08:49:57 EET | Pressmeddelande
En ny studie från HUS visar att behandlingen av icke rupturerade hjärnaneurysm i Helsingfors är exceptionellt säker och effektiv i internationell jämförelse. Resultaten publicerades i den prestigefyllda tidskriften Journal of Neurosurgery.
Aivovaltimopullistumien hoitotulokset HUSissa maailman kärkeä19.12.2025 08:49:57 EET | Tiedote
HUSissa tehty tuore tutkimus osoittaa, että puhkeamattomien aivovaltimopullistumien hoito on Helsingissä kansainvälisesti vertailtuna poikkeuksellisen turvallista ja tehokasta. Tulokset julkaistiin arvostetussa Journal of Neurosurgery -lehdessä.
Results in the treatment of intracranial aneurysms at HUS are among the best in the world19.12.2025 08:49:57 EET | Press release
A recent study conducted at HUS shows that the treatment of unruptured intracranial aneurysms in Helsinki is exceptionally safe and effective in international comparison. The results were published in the prestigious Journal of Neurosurgery.
HPV-test är effektivare och lika säkert som gynekologiskt cellprov vid screening för livmoderhalscancer15.12.2025 14:14:42 EET | Pressmeddelande
Förstadieförändringar upptäcks bättre vid HPV-screening än vid screening med gynekologiskt cellprov (papa). Det är viktigt att delta i screeningen när man får en kallelse.
HPV-testi on tehokkaampi ja yhtä turvallinen kuin papakoe kohdunkaulan syövän seulonnassa15.12.2025 14:14:42 EET | Tiedote
HPV-seulonta löytää esiastemuutokset papaseulontaa herkemmin. Seulontaan kannattaa osallistua, kun siihen saa kutsun.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom